Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.35
+0.05 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
11.39
+0.04 (0.35%)
After-hours: Mar 9, 2026, 5:26 PM EDT
Keros Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 224 | 620 | 641 | 1,191 | 1,323 | 1,369 | |
| Market Cap Growth | -49.91% | -3.27% | -46.17% | -9.94% | -3.39% | -16.27% | |
| Enterprise Value | -47 | -56 | 130 | 918 | 1,084 | 1,149 | |
| Last Close Price | 11.35 | 20.36 | 15.83 | 39.76 | 48.02 | 58.51 | |
| PE Ratio | 4.93 | 7.13 | - | - | - | - | |
| PS Ratio | 0.92 | 2.54 | 180.63 | 7888.64 | - | 68.11 | |
| PB Ratio | 0.73 | 2.05 | 1.12 | 3.59 | 4.77 | 5.63 | |
| P/TBV Ratio | 0.74 | 2.05 | 1.12 | 3.59 | 4.77 | 5.63 | |
| P/FCF Ratio | 2.11 | 5.85 | - | - | - | - | |
| P/OCF Ratio | 2.08 | 5.77 | - | - | - | - | |
| EV/Sales Ratio | - | - | 36.57 | 6076.87 | - | 57.16 | |
| Debt / Equity Ratio | 0.06 | 0.06 | 0.03 | 0.04 | 0.05 | 0.00 | |
| Debt / EBITDA Ratio | 0.21 | 0.21 | - | - | - | - | |
| Debt / FCF Ratio | 0.16 | 0.16 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.89 | -0.89 | -0.95 | -0.95 | -0.96 | -0.94 | |
| Net Debt / EBITDA Ratio | -3.75 | -3.75 | 2.58 | 1.87 | 2.33 | 4.09 | |
| Net Debt / FCF Ratio | -2.55 | -2.55 | 3.32 | 2.49 | 3.73 | 3.62 | |
| Asset Turnover | 0.51 | 0.51 | 0.01 | 0 | - | 0.08 | |
| Quick Ratio | 15.10 | 15.10 | 20.56 | 13.63 | 16.92 | 20.96 | |
| Current Ratio | 15.45 | 15.45 | 21.45 | 14.25 | 17.27 | 21.23 | |
| Return on Equity (ROE) | 19.90% | 19.90% | -41.46% | -50.19% | -40.22% | -23.27% | |
| Return on Assets (ROA) | 9.25% | 9.25% | -26.73% | -31.39% | -25.53% | -13.43% | |
| Return on Invested Capital (ROIC) | 222.22% | 211.85% | -916.80% | -1251.82% | -887.57% | -1027.86% | |
| Return on Capital Employed (ROCE) | 22.20% | 22.20% | -35.80% | -49.20% | -39.60% | -23.20% | |
| Earnings Yield | 38.88% | 14.03% | -29.22% | -12.84% | -7.91% | -4.29% | |
| FCF Yield | 47.34% | 17.08% | -25.39% | -10.66% | -5.39% | -4.61% | |
| Buyback Yield / Dilution | -1.13% | -1.13% | -27.13% | -16.66% | -8.17% | -50.48% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.